Inhibition of SGLT2 reduces hyperglycemia by decreasing glucose reabsorption in the kidneys leading to increased urinary glucose excretion, reductions in blood glucose and HbA1C [7]. This evidence concerns the gene SLC5A2 and Hyperglycemia.